Characterization of DNA binding, transcriptional activation, and regulated nuclear association of recombinant human NFATp by Kim, Loree J et al.
BMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
BMC Immunology (2000) 1:1 Research article
Characterization of DNA binding, transcriptional activation, and 
regulated nuclear association of recombinant human NFATp
Loree J Kim, Heather A Ferguson, Anita G Seto and James A Goodrich
Address:  Department of Chemistry and Biochemistry University of Colorado at Boulder, USA.
E-mail: Loree J Kim - loree.kim@u.washington.edu Heather A Ferguson - heather.ferguson@colorado.edu Anita G Seto - 
anita.seto@colorado.edu James A Goodrich - james.goodrich@colorado.edu 
Abstract
Background:  NFATp is one member of a family of transcriptional activators whose nuclear
accumulation and hence transcriptional activity is regulated in mammalian cells. Human NFATp
exists as a phosphoprotein in the cytoplasm of naive T cells. Upon antigen stimulation, NFATp is
dephosphorylated, accumulates in nuclei, and functions to regulate transcription of genes including
those encoding cytokines. While the properties of the DNA binding domain of NFATp have been
investigated in detail, biochemical studies of the transcriptional activation and regulated association
with nuclei have remained unexplored because of a lack of full length, purified recombinant NFATp.
Results:  We developed methods for expressing and purifying full length recombinant human
NFATp that has all of the properties known to be associated with native NFATp. The recombinant
NFATp binds DNA on its own and cooperatively with AP-1 proteins, activates transcription in
vitro, is phosphorylated, can be dephosphorylated by calcineurin, and exhibits regulated association
with nuclei in vitro. Importantly, activation by recombinant NFATp in a reconstituted transcription
system required regions of the protein outside of the central DNA binding domain.
Conclusions:  We conclude that NFATp is a bona fide transcriptional activator. Moreover, the
reagents  and methods that we developed  will  facilitate  future studies on the mechanisms of
transcriptional activation and nuclear accumulation by NFATp, a member of an important family of
transcriptional regulatory proteins.
Background
NFAT (Nuclear Factor of Activated T cells) is a family of
transcriptional activators that stimulate the expression
of genes including those encoding immunomodulatory
cytokines [1,2,3,4,5]. The transcriptional effects of indi-
vidual NFAT family members, including NFATp, NFATc,
NFAT3, NFAT4/x, and NFAT5, are beginning to emerge.
For example, NFATp, NFATc, and NFAT4 participate in
the activation of T and B cells [1, 6]. NFATc appears to be
critical for proper cardiac muscle-cell differentiation [7],
and NFAT3 functions in cardiac hypertrophy [8].
NFAT4/x has been implicated in development of imma-
ture thymocytes [5]. NFAT5 is involved in the transcrip-
tional regulation of osmotic stress response genes [9,
10].
All NFAT proteins except NFAT5 exist as phosphopro-
teins and are maintained in the cytoplasm of resting cells
[2, 3, 11, 12]. NFAT nuclear localization is regulated by
the action of a specific phosphatase and a number of ki-
nases [11,12,13,14,15,16,17,18,19,20,21]. In the case of T
cells, antigen stimulation elicits a calcium-dependent
signaling pathway that results in the activation of cal-
cineurin, which directly dephosphorylates NFATp in
preparation for nuclear import [11, 22]. Once in the nu-
cleus, NFAT can bind DNA elements in target promoters,
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often in association with other resident and co-induced
nuclear proteins [1].
Sequence comparison of NFAT proteins revealed that
the DNA-binding domain and a region referred to as the
NFAT homology region (NHR) share sequence similari-
ty, while other regions of the NFAT proteins share little
or no sequence similarity (a schematic of NFATp is
shown in Figure 1A) [1]. The DNA-binding domains are
similar among all NFAT members [4, 5, 10, 23, 24] and
allow NFAT proteins to bind DNA with sequence specif-
icity as monomers [4]. NFAT proteins (except NFAT5)
contain NHRs located N-terminal to the DNA binding
domain that function to regulate nuclear localization in
cells [12, 15, 25]. NFAT proteins are highly phosphorylat-
ed in the NHR, and the phosphatase calcineurin binds
directly to sequences in the NHR [11,12,13, 15, 19,
25,26,27]. Regions outside of the NHR and DNA binding
domain are thought to contain transcriptional activation
domains. For example, the N- and C-terminal regions
(amino acids 1-171 and 727-927, respectively) of murine
NFATp function as activation domains when fused to a
heterologous DNA binding domain in transient transfec-
tion assays in Jurkat cells [28]. The C-terminal regions of
NFAT proteins are unique in sequence and may be re-
sponsible for functional differences among NFAT family
members.
A number of activators can interact with NFAT to poten-
tiate synergistic activation of transcription on NFAT-re-
sponsive promoters that characteristically consist of
multiple NFAT-specific sites. One example is the inter-
leukin-2 (IL-2) promoter, which contains five NFAT
binding sites in a region spanning 250 bp upstream of
the TATA box [29, 30]. Four of the IL-2 NFAT sites are
part of composite elements consisting of NFAT and AP-1
sites that direct the cooperative binding of NFAT pro-
teins and AP-1 components [30]. In biochemical experi-
ments the DNA-binding domains of NFAT proteins (with
the exception of NFAT5) are sufficient for cooperative
DNA-binding in association with Fos/Jun heterodimers
[4, 10, 11]. As supported by structural analysis of the
NFAT/cJun/cFos/DNA complex, physical interactions
between the DNA binding domain of NFAT and the basic
leucine zipper regions of cJun and cFos enhance their in-
teraction with DNA [31].
To date, biochemical analysis of NFATp and other NFAT
members has been conducted using only portions and
not the full-length versions of these proteins. Recovery of
smaller, soluble, truncated forms of NFAT proteins is
feasible relative to the more difficult task of isolating ac-
tive forms of full-length NFAT proteins. Although such
domain-based investigations have been constructive in
studying the activity and the properties of the NFAT
DNA-binding domains, a biochemical analysis of tran-
scriptional activation and regulated nuclear association
of NFAT necessitated the characterization of full-length
proteins. This is mainly because the domains exhibiting
the transactivation properties and those controlling nu-
clear association are located in regions flanking the cen-
tral DNA binding domain. We therefore established
protocols for expressing and purifying full-length recom-
binant human NFATp. Utilizing a reconstituted tran-
scription system, we found that NFATp is a bona fide
transcriptional activator and that activation requires re-
gions of NFATp outside the DNA binding domain. In ad-
dition, we discovered that human NFATp produced in
insect cells using a recombinant baculovirus is a phos-
Figure 1
Expression  and  purification  of  recombinant  HA-NFATp  in
insect  cells.  (A) S c h e m a t i c  o f  t h e  f u n c t i o n a l  d o m a i n s  o f
NFATp. The DNA binding domain is central to the protein
and the minimal DNA binding domain is located between
amino acids 391 and 583. The N-terminal region (amino acids
1-390)  contains  an  activation  domain  rich  in  acidic  amino
acids and the region of the protein that binds calcineurin and
is involved in regulated nuclear localization. The C-terminal
region (amino acids 688-921) is unique to NFATp and con-
tains an activation domain that is rich in glutamines. (B) HA-
NFATp  was  purified  by  anti-HA  affinity  chromatography
from  baculovirus-infected  Hi-five cell  extracts.  Portions of
insect  cell  extract  containing  over-expressed  HA-NFATp
(lane 1), depleted extract (lane 2), and the purified/eluted
HA-NFATp (lane 3) were resolved by SDS-PAGE and stained
with coomassie brilliant blue. The position of full-length HA-
NFATp is indicated with an arrow. (C) HA-NFATp was puri-
fied  by  DNA  affinity  chromatography  from  baculovirus-
infected Hi-five cell extracts. Portions of insect cell extract
c o n t a i n i n g  o v e r - e x p r e s s e d  H A - N F A T p  ( l a n e  1 ) ,  d e p l e t e d
extract (lane 2), and the purified/eluted HA-NFATp (lane 3)
were  resolved  by  SDS-PAGE  and  stained  with  coomassie
brilliant blue. The position of full-length HA-NFATp is indi-
cated with an arrow.BMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
phoprotein that demonstrates calcineurin-regulated as-
sociation with nuclei in vitro.
Results and Discussion
Expression and purification of N-terminally tagged NFATp
We chose to begin our analysis of NFAT proteins in vitro
by working with human NFATp (B isoform, amino acids
1-921, Figure 1A). A recombinant baculovirus was creat-
ed for the expression of full length human NFATp with
an N-terminal HA tag. HA-NFATp was purified from
baculovirus-infected Hi-five cell extracts using anti-HA
affinity chromatography followed by elution with an HA-
epitope peptide (Figure 1B). The expressed HA-NFATp
protein was visible above background in infected Hi-five
cell extracts and was efficiently depleted by the anti-HA
resin (Figure 1B). This purification resulted in protein
that was nearly homogeneous. We also found that HA-
NFATp could be purified from cell extracts by DNA affin-
ity chromatography using an immobilized double
stranded oligonucleotide containing two high affinity
NFAT binding sites, followed by elution with NaCl (Fig-
ure 1C).
HA-NFATp binds DNA alone and cooperatively with cJun/
cFos
To test the DNA binding activity of recombinant HA-
NFATp and the ability to bind DNA cooperatively with
cJun/cFos we performed DNase I footprinting. We used
a DNA fragment from the human IL-2 promoter that
contains a high affinity NFAT site (-45 NFAT site) and a
composite element consisting of a low affinity NFAT site
and a low affinity AP1 site, to which the DNA binding do-
main of NFAT has been shown to bind cooperatively with
AP-1 proteins [4, 11]. When increasing amounts of HA-
NFATp were added to IL-2 DNA in the absence of cJun/
cFos, the -45 NFAT site was protected from DNase I di-
gestion, but as expected DNase I digestion of the com-
posite element was unaffected (Figure 2, lanes 1-5). In
other studies we found the observed equilibrium dissoci-
ation constant (obsKD) of recombinant HA-NFATp for a
high affinity NFAT site (mouse IL-4 promoter) to be 1
nM (data not shown). cJun/cFos alone protected the AP-
1 site of the composite element (Figure 2, lane 6). When
increasing amounts of HA-NFATp were added to IL-2
DNA in the presence of cJun/cFos, clear protection of
the entire composite site was observed (Figure 2, lanes 7-
10). From DNase I footprinting studies (Figure 2 and
data not shown) we conclude that recombinant HA-
NFATp binds DNA both on its own and in cooperation
with AP-1 proteins (cJun/cFos and cJun/cJun).
HA-NFATp activates transcription in a reconstituted in vit-
ro system
We tested purified HA-NFATp for the ability to activate
transcription in vitro. In designing an NFATp-respon-
sive DNA template, we positioned three high-affinity
NFAT-binding sites upstream of the adenovirus E1b
TATA box and the CAT gene. RNA transcripts produced
from the (NFAT)3-E1b-CAT plasmid in vitro can be de-
Figure 2
HA-NFATp binds DNA alone and cooperatively with cJun/
cFos. DNase I footprinting assays were performed to investi-
gate the binding of HA-NFATp to a region of the human IL-2
promoter in the absence (lanes 1-5) and presence (lanes 6-
10) of recombinant human cJun/cFos (3.2 nM). HA-NFATp
was added to reactions at the following final concentrations:
3 nM, lanes 2 and 7; 9 nM, lanes 3 and 8; 27 nM, lanes 4 and
9; and 54 nM, lanes 5 and 10. Footprinting reactions were
resolved by denaturing PAGE and analyzed with a Molecular
Dynamics  PhosphorImager.  Positions  relative  to  the  tran-
scriptional start site (+1) of the human IL-2 promoter are
indicated on the left. Locations of the previously character-
ized high affinity -45 NFAT site and composite element are
indicated on the right.BMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
tected by primer extension. Initial in vitro transcription
studies were performed using a nuclear extract from un-
stimulated Jurkat T cells. As shown in Figure 3A, HA-
NFATp activated transcription under these conditions.
Activation was dependent on the NFAT sites in the DNA
template, since a template lacking NFAT sites did not re-
spond to HA-NFATp (Figure 3B).
Although synergistic transcriptional activation presuma-
bly resulting from the cooperativity between NFATp and
AP-1 has been well established, NFATp transactivation
in the absence of AP-1 has not been demonstrated direct-
ly. For example, even though the NFAT sites in the DNA
template used in the transcription experiments in Fig-
ures 3A and 3B were high affinity NFAT binding sites
that were not part of a composite element, it remained
possible that AP-1 proteins in the nuclear extract con-
tributed to the activation observed. An analysis of the
transcriptional properties unique to NFATp required the
use of a reconstituted transcription system that is re-
sponsive to human NFATp, independent of AP-1 activity.
To this end we used an in vitro human RNA polymerase
II transcription system reconstituted from highly puri-
fied native (n) and recombinant (r) proteins, including
(r)TFIIA, (r)TFIIB, (n)TFIID, (r)TFIIE, (r)TFIIF,
(n)TFIIH, and (n)RNA polymerase II. Using a promoter
containing five high affinity AP-1 sites we found that this
transcription system responds well to recombinant
cJun/cFos, but does not respond to cFos alone (Figure
3C). This experiment demonstrates that the purified
transcription system is largely, if not entirely devoid of
AP-1 proteins. When NFATp was added to the reconsti-
tuted transcription system it activated transcription to
high levels from the DNA template containing three high
affinity NFAT sites (Figure 3D). This demonstrates that
NFATp is a bona fide transcriptional activator.
Activation domains of NFATp are required for transcrip-
tional activation in vitro
Functional analysis of regions of murine NFATp fused to
the yeast GAL4 DNA binding domain using transient
transfection assays detected two distinct transactivation
domains within the N- and C-terminal regions of NFATp
[28]. In this study, however, transcriptional activation by
NFATp was not dependent on the identified transactiva-
tion domains. The minimal DNA-binding domain of
NFATp was sufficient to stimulate reporter gene activa-
tion, presumably by recruitment of endogenous AP-1
components through cooperative DNA binding. It is not
possible to assess the true transactivation function of
NFAT proteins in reporter assays that use a promoter
comprised of NFAT/AP-1 composite elements in cells
with high levels of endogenous AP-1 proteins. Our find-
ing that recombinant HA-NFATp activates transcription
in a reconstituted transcription system provided compel-
ling evidence that NFATp is a bona fide activator. If
Figure 3
NFATp is a bona fide transcriptional activator. (A) Recom-
binant HA-NFATp activates transcription in an extract pre-
pared  from  unstimulated  Jurkat  cell  nuclei.  The  template
used contained three NFAT sites upstream of the E1b TATA
box and the CAT gene. Transcripts were analyzed by primer
extension using a CAT specific primer followed by denatur-
ing PAGE. The amounts of HA-NFATp used were: 12 ng and
40 ng. (B) Activation by HA-NFATp requires NFAT sites in
the DNA template. Basal and NFATp-activated transcription
were assessed using unstimulated Jurkat extract and either
the (NFAT)3-E1b-CAT template or a template lacking NFAT
sites (E1b-CAT). Transcripts were analyzed by primer exten-
s i o n  u s i n g  a  C A T  s p e c i f i c  p r i m e r  f o l l o w e d  b y  d e n a t u r i n g
PAGE. (C) Reconstitution of a purified RNA polymerase II
transcription system that is devoid of AP-1 proteins. Tran-
scription was reconstituted from highly purified factors and
tested for response to cJun/cFos and cFos alone. The DNA
template contained five high affinity AP-1 site upstream of the
E1b TATA box and the CAT gene. Transcripts were ana-
lyzed by primer extension using a CAT specific primer fol-
lowed  by  denaturing  PAGE.  (D)  HA-NFATp  activates
transcription  in  a  reconstituted  transcription  system.  The
D N A  t e m p l a t e  w a s  ( N F A T ) 3-E1b-CAT.  The  transcription
system consisted of highly purified recombinant and native
general transcription factors as described in the text.BMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
NFATp acted alone to stimulate transcription in the re-
constituted transcription system then the activation we
observed would be dependent on the activation domains
of NFATp. We therefore applied in vitro biochemical
methods for the characterization of NFATp functional
domains.
Recombinant baculoviruses were created for the expres-
sion of full-length NFATp (amino acids 1-921) and the
minimal DNA binding domain of NFATp (amino acids
391-583) fused to GST. GST-NFATp(1-921) and GST-
NFATp(391-583) were expressed in insect cells, purified
on glutathione sepharose beads, and eluted with glutath-
ione. Figure 4A shows the purity of these two proteins as
assessed by SDS-PAGE and staining with coomassie bril-
liant blue. Both proteins were competent for binding a
high affinity NFAT site when tested in electrophoretic
mobility shift assays (Figure 4B). The transactivation
properties of the two proteins were tested by in vitro
transcription using the reconstituted transcription sys-
tem and a DNA template consisting of three high affinity
NFAT sites upstream of the adenovirus major late core
promoter and a 200 bp G-less cassette. As shown in Fig-
ure 4C, GST-NFATp(1-921) activated transcription,
while GST-NFATp(391-583) did not activate transcrip-
tion. Thus, regions outside of the minimal DNA binding
domain were required for transcriptional activation in a
reconstituted transcription system. Taken together, our
results directly demonstrate that NFATp is a transcrip-
tional activator.
Recombinant HA-NFATp is phosphorylated and exhibits 
regulated association with nuclei in vitro
In unstimulated T cells NFATp exists in a highly phos-
phorylated form that when analyzed by SDS-PAGE has
an apparent molecular weight that is significantly larger
than its predicted molecular weight [2, 22, 26]. When T
cells are stimulated, NFATp is dephosphorylated by cal-
cineurin and it migrates farther on SDS gels than its
Figure 4
Transcriptional activation by NFATp in a reconstituted transcription system is dependent on regions outside of the DNA bind-
ing domain. (A) GST-fusions to full-length NFATp (amino acids 1-921) and the DNA-binding domain of NFATp (amino acids
391-583) were expressed in insect cells, purified by affinity chromatography, and eluted with glutathione. The purified proteins
were analyzed by SDS-PAGE and stained with coomassie brilliant blue. (B) GST-NFATp(1-921) and GST-NFATp(391-583) are
active for binding DNA. Proteins were incubated with a double stranded oligonucleotide containing a consensus NFAT-binding
site. Protein/DNA complexes and free DNA were resolved on a native 4% polyacrylamide gel, and detected by autoradiogra-
phy. The final concentrations of GST-NFATp(1-921) and GST-NFATp(391-583) were: 17 nM (lanes 2 and 5) and 35 nM (lanes
3 and 6). (C) GST-NFATp(1-921), but not GST-NFATp(391-583) activates transcription in a reconstituted transcription sys-
tem. Transcription reactions were performed in a reconstituted RNA polymerase II transcription system using a DNA template
consisting of three high affinity NFAT sites upstream of the adenovirus major late core promoter and a 200 bp G-less cassette.
40 ng of either GST-NFATp(1-921) and GST-NFATp(391-583) were added to reactions as indicated. Transcripts were purified,
resolved by denaturing PAGE, and visualized with a PhosphorImager.BMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
phosphorylated counterpart. Similarly, when NFATp is
purified from unstimulated T cells and subsequently de-
phosphorylated by calcineurin in vitro, its migration on
SDS gels increases (i.e. its apparent molecular weight de-
creases) [2, 11, 26]. Most of the many phosphorylation
sites in NFATp are in the N-terminal region of the pro-
tein [15, 27]. Upon purifying recombinant HA-NFATp,
we noticed that the protein migrated at an apparent mo-
lecular weight similar to the native NFATp in unstimu-
lated T cells (approximately 140 kD when compared to
size standards). This led us to hypothesize that the re-
combinant HA-NFATp purified from baculovirus infect-
ed insect cells was phosphorylated. To test this
hypothesis and to determine if phosphorylation of a dis-
tinct region of HA-NFATp was responsible for aberrant
migration in SDS gels, we expressed and purified full-
length HA-NFATp and three deletions: HA-NFATp(331-
921), HA-NFATp(1-722), and HA-NFATp(331-722). All
four proteins were expressed in insect cells from recom-
binant baculoviruses, purified by anti-HA affinity chro-
matography, and eluted with HA-epitope peptide. After
purification we treated the four proteins with a combina-
tion of calcineurin and calmodulin to remove phosphates
attached to serines and threonines on the recombinant
proteins. The phosphatase treated proteins as well as
mock treated controls were resolved by SDS-PAGE and
visualized by silver staining. As shown in Figure 5A, the
apparent molecular weight of full-length HA-NFATp was
significantly decreased by the phosphatase treatment,
demonstrating that recombinant HA-NFATp purified
from insect cells is phosphorylated. The shift in migra-
tion of HA-NFATp was dependent on both calcineurin
and calmodulin, and was not efficiently produced with
other phosphatases (data not shown). Of the three dele-
tion proteins, only HA-NFATp(1-722) showed a change
in migration upon phosphatase treatment; the positions
at which both HA-NFATp(331-921) and HA-
NFATp(331-722) migrated on SDS gels were not affected
by phosphatase treatment. Thus, the N-terminal region
of NFATp (amino acids 1-330) was required to observe a
phosphorylation-dependent decrease in migration of the
recombinant HA-NFATp. This suggested that the major
phosphorylation sites on insect cell produced NFATp
were in the N-terminal region, as is the case for native
NFATp in mammalian T cells [27]. This was confirmed
by performing mass spectrometry on peptides recovered
from a tryptic digest of recombinant NFATp (W. Clem-
ents and J. Goodrich, unpublished data).
The phosphorylation state of NFATp controls its nuclear
localization in cells. Specifically, phosphorylated NFATp
is cytoplasmic, and upon dephosphorylation NFATp ac-
cumulates in the nucleus [1]. Upon discovering that re-
combinant HA-NFATp was phosphorylated in its N-
terminal region we asked if the phosphorylation state of
HA-NFATp would influence its ability to associate with
nuclei in an in vitro assay. Nuclei were prepared from
HeLa cells. HA-NFATp was either treated with cal-
cineurin and calmodulin or mock treated, and the two
proteins were then mixed with the nuclei. After incuba-
tion, nuclei were pelleted by centrifugation and thereby
separated from unbound protein, which remained in the
supernatant. The nuclei were washed, and protein asso-
ciated with the nuclei as well as protein in the superna-
tants was solubilized in SDS sample buffer, resolved by
SDS-PAGE, and analyzed by protein immunoblotting
with anti-HA antibody. As shown in Figure 5B, the ma-
jority of phosphorylated HA-NFATp was found in the su-
pernatant and not in the pellet, while approximately 50%
of the dephosphorylated NFATp was found associated
with nuclei. Moreover, when HA-NFATp(331-722),
which was not highly phosphorylated, was tested in the
nuclei-association assay it was primarily found in the
pellet with the nuclei, regardless of whether it was treat-
ed with calcineurin or not (data not shown). Taken to-
gether these data lead us to conclude that the
phosphorylation state of recombinant HA-NFATp can
control its association with nuclei in vitro in a manner
that is very similar to the regulation of nuclear associa-
tion observed for NFAT proteins in cells.
Conclusions
We have found that human NFATp is a bona fide tran-
scriptional activator and that regions outside of the cen-
tral DNA binding domain are required for NFATp to
activate transcription. Our experiments in a reconstitut-
ed transcription system lacking contaminating AP-1 pro-
teins and using DNA templates with high affinity NFAT
sites demonstrate that NFATp can function as a tran-
scriptional activator on its own. We have also shown that
recombinant NFATp purified from insect cells is a phos-
phoprotein that exhibits association with nuclei in vitro
only after dephosphorylation by calcineurin. The recom-
binant full length and deletion mutants of human
NFATp used in the studies described here as well as the
methods that we have developed will be valuable for fu-
ture biochemical studies of the function of NFATp in
DNA binding, transcriptional activation, phosphoryla-
tion/dephosphorylation, and nuclear association.
Materials and Methods
Plasmids and baculoviruses
A plasmid pREP-NFATp was provided by Tim Hoey (Tu-
larik, Inc.) [4]. pBS-KS+-NFATp was generated by di-
gesting pREP-NFATp with BssH II and Dra I, filling in
the ends with Klenow, and ligating the resulting frag-
ment into the Sma I site of pBS-KS+. pVL1392-HAX-
NFATp was generated by subcloning a fragment excised
from pBS-KS+-NFATp with Spe I and EcoR I into
pVL1392-HAX (gift of S. Ruppert and R. Tjian) digested
with Spe I and EcoR I. pBS-KS+-NFATp(NdeI), whichBMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
has an Nde I site, containing the NFATp translational
start site ATG, was generated in two steps. A region of
NFATp spanning the translational start site ATG and an
internal Mro I restriction site was amplified by PCR, cre-
ating a product with an Nde I site at the translational
start site ATG as well as an upstream Xba I site. The PCR
product was digested with Xba I and Mro I and ligated
into pBS-KS+-NFATp that had been digested with Xba I
and Mro I. pVL1392-HAX-NFATp(1-722) was made by
subcloning a Nde I - Msc I fragment from pBS-KS+-
NFATp(NdeI) into the Nde I and Sma I sites of pVL1392-
HAX. pVL1393-HAX-NFATp(331-921) was made by di-
gesting pBS-KS+-NFATp with SgrA I and filling in the
overhang by treatment with Klenow. After further diges-
tion with EcoR I, the NFAT DNA fragment was isolated
and ligated into the Sma I and EcoR I sites of
pVL1393HAX. A pVL1392-HAX-NFATp(331-722) was
made by subcloning a Nde I - Sma I fragment from
pGEX-NFATp(331-722) (J. Goodrich, unpublished) into
the Nde I and Sma I sites of pVL1392-HAX.
pVL-GST-NFATp was created by subcloning a Nde I -
EcoR I fragment containing the NFATp cDNA from pBS-
KS+-NFATp(NdeI) into the Nde I and EcoR I sites of
pVL1392-GST (gift of S. Ruppert and R. Tjian). pVL-
GST-NFATp(391-583) was generated in two steps. First,
pBS-NFATp(391-583) was created using single-stranded
pBS-KS+-NFATp(NdeI) for site-directed mutagenesis
with two oligonucleotides: a unique in-frame ATG codon
contained in an Nde I site was created in place of the co-
don for amino acid 390 using an oligonucleotide of se-
quence 5'-CATCTGCAGCATCCATATGACTGCATC
CCTC-3' and a stop codon was created in the NFATp
cDNA after amino acid 583 using an oligonucleotide of
sequence 5'-GTTGAAAGACAATAAACAGAATTCT-
GCCTGGTCTATG-3'. In the second step, the Nde I EcoR
I fragment from pBS-NFATp(391-583) was ligated into
the Nde I and EcoR I sites of pVL1392-GST.
p(NFAT)3-E1b-CAT, used as template DNA in the in vit-
ro transcription assays, was created by inserting three di-
rect copies of the murine IL-4 high affinity NFAT site
Figure 5
Recombinant HA-NFATp is phosphorylated and dis-
plays regulated nuclear association in vitro. (A) HA-
NFATp is phosphorylated in its N-terminal region and
can be dephosphorylated by calcineurin in vitro. Full
length NFATp (lanes 1 and 2) and three deletion
mutants (lanes 3-8) were expressed with N-terminal
HA-tags using recombinant baculoviruses. All four pro-
teins were purified by anti-HA affinity chromatography
and eluted with HA-epitope peptide. The proteins were
individually incubated with calcineurin and calmodulin
(CaM, even lanes) or mock treated in reactions lacking
calcineurin and calmodulin (odd lanes). Proteins were
resolved by SDS-PAGE and visualized by silver stain-
ing. The position of the calcineurin in the SDS gel is
indicated. Note the shift in migration of HA-NFATp(1-
921) and HA-NFATp(1-722) upon treatment with phos-
phatase. (B) HA-NFATp associates with nuclei in vitro
only after treatment with calcineurin. HA-NFATp that
was pre-treated with calcineurin and CaM (lanes 5 and
6) or mock treated (lanes 3 and 4) was mixed with HeLa
nuclei. A control reaction was performed without added
HA-NFATp (lanes 1 and 2). After incubation, the nuclei
were pelleted by centrifugation and washed. Protein in
the pelleted nuclei fractions (P) or supernatant fractions
(S) were resolved by SDS-PAGE and analyzed by pro-
tein immunoblotting with anti-HA antibody. The posi-
tions of phosphorylated HA-NFATp and
dephosphorylated HA-NFATp are indicated. The posi-
tion of a non-specific protein in HeLa nuclei that is rec-
ognized by the anti-HA antibody is indicated with an
asterisk.BMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
(region -82 to -64 of the murine IL-4 promoter) into the
Xba I site of plasmid E1b-CAT. p(NFAT)3-MLP-G-less
consists of three direct copies of the murine IL-4 high af-
finity NFAT site (region -82 to -64 of the murine IL-4
promoter) upstream of an adenovirus major late core
promoter (-53 to +10) and a 200 bp G-less cassette. To
create p(NFAT)3-MLP-G-less a DNA fragment contain-
ing the three NFAT sites was recovered from the diges-
tion of the p(NFAT)3-E1b-CAT with Xba I and ligated
into the Xba I of p∆ ML200 (gift of J. Parvin) [32, 33].
p(AP-1)5-E1b-CAT has been described previously [34].
Baculovirus stocks were produced according to standard
procedures by individually cotransfecting parental plas-
mids (described above) along with Baculogold DNA
(PharmMingen) into Sf-9 insect cells.
Expression and purification of recombinant proteins
For the preparation of HA-NFATp, Hi-five cells were in-
fected with the HA-NFATp virus for 44 hr at 27° C. Cell
were harvested by low-speed centrifugation and resus-
pended in lysis buffer (20 mM Tris (pH 7.9), 20% (v/v)
glycerol, 1 mM EDTA, 0.5 M NaCl, 0.1% NP-40, 0.2 mM
PMSF, 1 µ g/ml leupeptin, 1.4 µ g/ml pepstatin A, and 1
mM DTT). Sonication was performed at 4° C for 5 min be-
fore centrifugation at 14,000 rpm for 20-30 min. The re-
combinant protein was purified on anti-HA-conjugated
beads and washed two times in TGEMD buffer (20 mM
Tris (pH 7.9), 20% (v/v) glycerol, 1 mM EDTA, 5 mM
MgCl2, 0.1% NP-40, 0.2 mM PMSF, 1 µ g/ml leupeptin,
1.4 µ g/ml pepstatin A, and 1 mM DTT) containing 1 M
NaCl and an additional two times in TGEMD buffer con-
taining 0.2 M NaCl. HA-NFATp was subsequently eluted
with 1 mg/ml HA peptide resuspended in elution buffer
(20 mM Tris (pH 7.9), 20% (v/v) glycerol, 1 mM EDTA,
5 mM MgCl2, 0.2 M NaCl, 0.1% NP-40, 0.2 mM PMSF, 1
µ g/ml leupeptin, 1.4 µ g/ml pepstatin A, and 1 mM DTT).
The eluate was spun through a Millex-GV4 filter, frozen
in liquid nitrogen, and stored at -80° C. A similar proto-
col was used for the expression and purification of HA-
NFATp(1-722), HA-NFATp(331-921), and HA-
NFATp(331-722).
HA-NFATp was purified from insect cell extracts by DNA
affinity chromatography. Insect cell extracts were passed
over a column consisting of a double stranded DNA con-
taining two high affinity NFAT sites immobilized on
streptavidin sepharose via a biotin at one 5' end. Protein
was step-eluted off of the resin with TGEMD buffer con-
taining increasing concentrations of NaCl: 0.2 M, 0.5 M
and 1.0 M. Most of the HA-NFATp was found in the 1.0
M NaCl fraction and was highly purified (shown in Fig-
ure 1C).
Recombinant GST-NFAT proteins were purified from
Hi-five cell extracts (48 hr post-baculovirus infection) by
affinity chromatography using glutathione-conjugated
sepharose beads. Cell lysates (prepared as described
above) were incubated with glutathione sepharose beads
for 2 hours at 4° C. This was followed by extensive washes
in TGEMD (1.0 M and 0.2 M NaCl). The purified proteins
were eluted with reduced glutathione at 1 mg/ml in elu-
tion buffer (100 mM Tris (pH 7.9), 120 mM NaCl). The
eluted fractions were spun through 0.22 µ M Millex fil-
ters (Millipore), dialyzed for 6 hours at 4° C in dialysis
buffer (20 mM Tris (pH 7.9), 100 mM KCl, 20% (v/v)
glycerol, and 1 mM DTT), frozen in liquid nitrogen, and
stored at -80° C. The expression and purification of re-
combinant human cJun/cFos (full length proteins) will
be described elsewhere (H. Ferguson and J. Goodrich,
manuscript in preparation).
DNase I footprinting
DNase I footprints were performed with a 187 bp DNA
fragment containing the -111 to +42 region of the human
IL-2 promoter and some surrounding vector DNA. The
DNA fragment was generated by PCR and was 32P-la-
beled on the 5'-end of the nontemplate strand. Reactions
contained poly(dG-dC) • poly(dG-dC) as a nonspecific
competitor (final concentration of 2 µ g/ml). HA-NFATp
and cJun/cFos (amounts indicated in Figure 2 legend)
were incubated with promoter DNA (final concentration
0.2 nM) for 15 min at 30° C under buffer conditions that
were identical to those used for transcription in a reac-
tion volume of 20 µ l. 2 µ l of a solution containing 0.06
Units/µ l DNase I (Promega) and 10 mM CaCl2 was add-
ed to each reaction. After a 30 sec incubation at 30° C, re-
actions were stopped with 40 µ l of stop solution
containing 25 mM EDTA, 125 mM KCl, and 10 µ g of car-
rier yeast RNA. SDS was added to each reaction to a final
concentration of 0.5%. Reactions were incubated at 65° C
for 15 min and then placed on ice for 10 min. After a 10
min spin at 14,000 rpm in a microcentrifuge, the super-
natants were transferred to new tubes. DNA was ethanol
precipitated and resuspended in formamide loading
buffer. Products were resolved by 8% denaturing PAGE.
In vitro transcription
Transcription reactions using the reconstituted tran-
scription system were performed as previously described
[34] with the following modifications. Each reaction con-
tained 50 ng of either p(NFAT)3-E1b-CAT, or p(NFAT)3-
MLP-G-less. Where indicated recombinant NFATp pro-
teins were pre-incubated with promoter DNA for five
min at 30° C prior to the addition of the remaining gener-
al transcription factors (TFIIA, TFIIB, TFIID, TFIIE,
TFIIF, and TFIIH) and RNA polymerase II. After the ad-
dition of general transcription factors, reactions were in-
cubated 30° C for 20 min. Nucleoside triphosphates were
added and RNA synthesis was allowed to proceed for 20
min at 30° C. Transcription reactions were stopped, RNABMC Immunology (2000) 1:1 http://www.biomedcentral.com/1471-2172/1/1
transcripts were processed, and where indicated primer
extension was performed as previously described [34].
Electrophoretic mobility shift assays
The binding reactions were performed in a total volume
of 10 µ l in a buffer consisting of 10 mM Tris (pH 7.9), 50
mM KCl, 10% glycerol, 50 µ g/ml BSA, 1 mM DTT, 10 mM
Hepes, 5 mM MgCl2, 10 µ g/ml calf thymus DNA, and
1.25 fmoles of double-stranded oligonucleotide bearing a
high-affinity NFAT site (murine IL-4 promoter from -82
to -64). GST-NFATp(1-921) and GST-NFATp(391-583)
were incubated with the template for 20 min at 30° C.
Protein/DNA complexes and free DNA were resolved on
4% native polyacrylamide gels in 0.5X TBE for 4 hours at
4° C. Gels were dried on 3 mm chromatography paper
(Whatman) and subjected to PhosphorImager analysis.
Dephosphorylation of recombinant NFATp proteins
Recombinant HA-tagged NFATp proteins (approximate-
ly 500 ng) were incubated with calcineurin (500 ng, Sig-
ma) and calmodulin (200 ng, Sigma) in 21 µ l of buffer
that had the following final concentrations of compo-
nents: 7 mM Tris-HCl, 5 mM Hepes (pH 7.6), 90 mM Na-
Cl, 15 mM betamercaptoethanol, 0.3 mM DTT, 1 mM
EDTA, 30% (v/v) glycerol, 3 mM MgCl2, and 1.5 mM
MnCl2. Control reactions were performed with NFATp
proteins in the absence of added calcineurin and calmod-
ulin. All reactions were incubated at 30° C for 20 min.
Products were resolved on and 8% SDS gel and visual-
ized by silver staining.
Nuclei association assays
Nuclei were prepared from HeLa cells by standard pro-
cedures [35] and resuspended in 10 packed nuclei vol-
umes of buffer A (10 mM Hepes (pH 7.9) 1.5 mM MgCl2,
10 mM KCl, 0.5 mM DTT, and 0.5 mM PMSF). For each
binding reaction, 5 µ l of NFATp dephosphorylation reac-
tion (or a mock treated control reaction) was added to 10
µ l of nuclei slurry and allowed to incubate with gentle
mixing for 10 min at room temperature. After incuba-
tion, nuclei were pelleted by centrifugation in a micro-
fuge at 3000 rpm for 2 min. Supernatants were
transferred to new tubes and nuclei were subsequently
washed two times with 50 µ l of buffer A. Protein in the
supernatant and pellet fractions were dissolved in SDS
sample buffer, resolved by 8% SDS-PAGE, transferred to
nitrocellulose, and immunoblotted with anti-HA anti-
body.
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